Trade & Tariffs

Why it matters

Lucid's liquidity runway extending only through H1 2027 means the company will almost certainly need additional capital before Cosmos volumes are sufficient to alter the cash burn trajectory. PIF's shift from equity injections to revolving credit is a meaningful signal: Saudi Arabia is no longer willing to absorb dilution risk at current valuations. A further equity raise at or near current prices would be deeply dilutive to retail holders, and the $2 billion credit facility carry terms will constrain operating flexibility precisely as midsize platform capex peaks in 2026.

Why it matters

Rates at 6.11% and trending toward 6.5% will extend the lock-in effect through the spring selling season, compressing existing home inventory and new-home traffic simultaneously. D.R. Horton, Lennar, and PulteGroup all issued FY guidance before the Iran escalation pushed the 10-year Treasury higher; those targets now look stale. Mortgage originators including United Wholesale Mortgage lose the seasonal volume uplift they were counting on to offset margin pressure from the refi drought.

Why it matters

If this lawsuit advances beyond early motions, it could create a template for class action litigation against any large retailer that passed tariff costs to consumers and subsequently received refunds. Companies with formalised membership structures, such as Sam's Club under Walmart, are most exposed because the documented customer relationship makes it easier to establish a plausible privity argument. Retailers with high import concentrations in tariff-sensitive categories, including Target and Best Buy, face a secondary legal risk even without membership models if plaintiffs' attorneys test the theory on a looser standing basis. Legal defence costs alone could represent a material but underappreciated line item in retail operating expenses through 2026.

Why it matters

Nvidia's $2 billion equity stake in Nebius extends a pattern of the chipmaker using direct investment to lock preferred infrastructure partners into its hardware ecosystem. This creates a structural disadvantage for rival chip suppliers, particularly AMD and Intel, who lack the balance sheet willingness or strategic incentive to match these capital commitments. Neocloud operators evaluating GPU procurement decisions will face implicit pressure to maintain Nvidia hardware standardisation when the chipmaker is also a significant shareholder, effectively narrowing the competitive surface for AMD's MI300X and Intel's Gaudi accelerators in the AI cloud segment. Portfolio managers long AMD or Intel on the thesis of GPU market share gains should revisit timeline assumptions for neocloud adoption of alternative silicon.

Why it matters

Specialty pharmaceutical companies with pipeline assets targeting rare neurological or genetic disorders stand to benefit from the FDA's demonstrated willingness to approve first-in-class treatments for ultra-orphan conditions. Firms such as PTC Therapeutics, Ultragenyx, and Passage Bio, which pursue similar CNS rare-disease indications, may see improved investor confidence in their regulatory pathways.

Why it matters

Oracle's demonstrated ability to convert AI infrastructure commitments into contracted cloud revenue strengthens the investment case for other heavily indebted AI infrastructure plays. Companies such as CoreWeave and data centre REITs like Equinix and Digital Realty, which carry similar debt-funded expansion profiles, may see their credit default swap spreads tighten as bond markets reassess the risk premium embedded in AI-related capital expenditure programmes.

Why it matters

A record Chinese trade surplus will sharpen political pressure on Beijing from both Washington and Brussels, raising the probability of additional tariff escalation or anti-dumping actions in 2026. Companies with significant China-dependent supply chains, including European industrial names and US consumer goods importers such as Nike and Hasbro, face heightened policy risk on their sourcing costs and market access.

Why it matters

The 15% service fee cap at Live Nation amphitheaters, combined with the requirement to open venues to rival primary ticketing platforms, creates direct competitive pressure on Ticketmaster's fee-based revenue model. Secondary ticketing marketplaces such as SeatGeek and AXS, which have been largely shut out of primary distribution at major venues, stand to gain material market share if venue operators exercise their new right to allocate up to 50% of inventory through alternatives, compressing Ticketmaster's take rate across the industry.

Why it matters

The settlement effectively validates a distribution model in which branded pharmaceutical manufacturers partner with telehealth platforms rather than litigate against them. This raises the prospect of Eli Lilly, which makes rival obesity drug Zepbound, pursuing a similar arrangement with digital health companies such as Ro or Noom, potentially reshuffling the competitive landscape for compounded GLP-1 alternatives across the sector.

Why it matters

Airlines face a severe and potentially existential margin squeeze. Jet fuel typically represents 20-25 per cent of carrier operating costs, and hedging books at most major US carriers extend only six to twelve months at partial coverage ratios. With Brent above $110 and trending toward $120, unhedged exposure will overwhelm yield management capacity. Delta, United, and American are the most exposed given their domestic route density; European carriers Lufthansa and IAG face the additional burden of weakening local currencies against a surging dollar, compounding fuel costs in euro and sterling terms.